S. Giraud and J. Bouchara, Scedosporium apiospermum Complex: Diagnosis and Species Identification, Current Fungal Infection Reports, vol.147, issue.6, pp.211-219, 2014.
DOI : 10.1099/00221287-147-6-1499

A. Ramirez-garcia, A. Pellon, and A. Rementeria, Scedosporium and Lomentospora: an updated overview of underrated opportunists, Medical Mycology, vol.61, issue.suppl_1, pp.102-125, 2018.
DOI : 10.1093/mmy/myx113
URL : https://hal.archives-ouvertes.fr/hal-01789215

R. Zouhair, A. Rougeron, B. Razafimandimby, A. Kobi, J. Bouchara et al., complex in French patients with cystic fibrosis, Medical Mycology, vol.60, issue.6, pp.603-613, 2013.
DOI : 10.1128/AAC.00981-06

L. Sedlacek, B. Graf, and C. Schwarz, Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium, Journal of Cystic Fibrosis, vol.14, issue.2, pp.237-241, 2015.
DOI : 10.1016/j.jcf.2014.12.014

C. Blyth, A. Harun, and P. Middleton, Species in Respiratory Tract Specimens from Patients with Cystic Fibrosis by Use of Selective Media, Journal of Clinical Microbiology, vol.48, issue.1, pp.314-316, 2010.
DOI : 10.1128/JCM.01470-09
URL : http://jcm.asm.org/content/48/1/314.full.pdf

B. Cimon, J. Carrère, and J. Chazalette, Fungal colonization and immune response to fungi in cystic fibrosis, J Mycol Méd, vol.5, pp.211-216, 1995.

B. Cimon, J. Carrère, J. Vinatier, J. Chazalette, D. Chabasse et al., Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.1, pp.53-56, 2000.
DOI : 10.1007/s100960050011

M. Pihet, J. Carrère, and B. Cimon, Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis ??? a review, Medical Mycology, vol.40, issue.1, pp.387-397, 2008.
DOI : 10.1128/JCM.40.9.3544-3545.2002

A. Paugam, M. Baixench, and N. Demazes-dufeu, Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France, Medical Mycology, vol.21, issue.3, pp.32-36, 2010.
DOI : 10.1002/(SICI)1099-0496(199601)21:1<6::AID-PPUL1>3.0.CO;2-R

A. Borman, M. Palmer, and L. Delhaes, Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi, Medical Mycology, vol.47, issue.O1, pp.88-97, 2010.
DOI : 10.1128/JCM.01685-08
URL : https://hal.archives-ouvertes.fr/hal-01118199

C. Schwarz, P. Vandeputte, and A. Rougeron, Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis, Medical Mycology, vol.30, issue.1, pp.42-59, 2018.
DOI : 10.1093/mmy/myx106
URL : https://hal.archives-ouvertes.fr/hal-01789211

A. Defontaine, R. Zouhair, and B. Cimon, Genotyping Study of Scedosporium apiospermum Isolates from Patients with Cystic Fibrosis, Journal of Clinical Microbiology, vol.40, issue.6, pp.2108-2114, 2002.
DOI : 10.1128/JCM.40.6.2108-2114.2002
URL : http://jcm.asm.org/content/40/6/2108.full.pdf

V. Tsuji, O. , C. Rivera, T. Rondánrond´rondán, Z. et al., Endobronquitis por Scedosporium apiospermum en una ni??a con fibrosis qu??stica, Revista Iberoamericana de Micolog??a, vol.23, issue.4, pp.245-248, 2006.
DOI : 10.1016/S1130-1406(06)70054-7

B. Castiglioni, D. Sutton, M. Rinaldi, J. Fung, and S. Kusne, Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the Literature, Medicine, vol.81, issue.5, pp.333-348, 2002.
DOI : 10.1097/00005792-200209000-00001

S. Husain, P. Muñozmu?muñoz, and G. Forrest, Infections Due to Scedosporium apiospermum and Scedosporium prolificans in Transplant Recipients: Clinical Characteristics and Impact of Antifungal Agent Therapy on Outcome, Clinical Infectious Diseases, vol.47, issue.1, pp.89-99, 2005.
DOI : 10.1128/AAC.47.1.106-117.2003

F. Symoens, C. Knoop, and M. Schrooyen, Disseminated Scedosporium apiospermum Infection in a Cystic Fibrosis Patient After Double-lung Transplantation, The Journal of Heart and Lung Transplantation, vol.25, issue.5, pp.603-607, 2006.
DOI : 10.1016/j.healun.2005.12.011

H. Sahi, R. Avery, and O. Minai, Scedosporium apiospermum (Pseudoallescheria boydii) Infection in Lung Transplant Recipients, The Journal of Heart and Lung Transplantation, vol.26, issue.4, pp.350-356, 2007.
DOI : 10.1016/j.healun.2007.01.011

F. Morio, D. Horeau-langlard, and F. Gay-andrieu, Disseminated Scedosporium/Pseudallescheria Infection after Double-Lung Transplantation in Patients with Cystic Fibrosis, Journal of Clinical Microbiology, vol.48, issue.5, pp.1978-1982, 2010.
DOI : 10.1128/JCM.01840-09
URL : http://jcm.asm.org/content/48/5/1978.full.pdf

B. Babior, The respiratory burst of phagocytes., Journal of Clinical Investigation, vol.73, issue.3, pp.599-601, 1984.
DOI : 10.1172/JCI111249

F. Fang, Antimicrobial reactive oxygen and nitrogen species: concepts and controversies, Nature Reviews Microbiology, vol.115, issue.Suppl. 1, pp.820-832, 2004.
DOI : 10.1016/S0092-8674(03)00803-1

N. Iovine, S. Pursnani, A. Voldman, G. Wasserman, M. Blaser et al., Reactive Nitrogen Species Contribute to Innate Host Defense against Campylobacter jejuni, Infection and Immunity, vol.76, issue.3, pp.986-993, 2008.
DOI : 10.1128/IAI.01063-07
URL : http://iai.asm.org/content/76/3/986.full.pdf

E. Campbell and S. Colgan, Neutrophils and inflammatory metabolism in antimicrobial functions of the mucosa, Journal of Leukocyte Biology, vol.98, issue.4, pp.517-522, 2015.
DOI : 10.1189/jlb.3MR1114-556R

C. Staerck, A. Gastebois, and P. Vandeputte, Microbial antioxidant defense enzymes, Microbial Pathogenesis, vol.110, pp.56-65, 2017.
DOI : 10.1016/j.micpath.2017.06.015

D. Reid, N. Misso, S. Aggarwal, P. Thompson, and E. Walters, Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis, Respirology, vol.7, issue.1, pp.63-69, 2007.
DOI : 10.1152/ajpcell.00188.2002

F. Galli, A. Battistoni, and R. Gambari, Oxidative stress and antioxidant therapy in cystic fibrosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1822, issue.5, pp.690-713, 2012.
DOI : 10.1016/j.bbadis.2011.12.012

T. Belozerskaya and N. Gessler, Reactive oxygen species and the strategy of antioxidant defense in fungi: A review, Applied Biochemistry and Microbiology, vol.1067, issue.1, pp.506-515, 2007.
DOI : 10.1152/physrev.00018.2001

M. Forrester and M. Foster, Protection from nitrosative stress: A central role for microbial flavohemoglobin, Free Radical Biology and Medicine, vol.52, issue.9, pp.1620-1633, 2012.
DOI : 10.1016/j.freeradbiomed.2012.01.028

P. Vandeputte, S. Ghamrawi, and M. Rechenmann, Draft Genome Sequence of the Pathogenic Fungus Scedosporium apiospermum, Genome Announcements, vol.56, issue.5, pp.988-1002, 2014.
DOI : 10.1128/AAC.05910-11
URL : http://genomea.asm.org/content/2/5/e00988-14.full.pdf

G. Larcher, B. Cimon, F. Symoens, G. Tronchin, D. Chabasse et al., Biochemical Journal, vol.315, issue.1, pp.119-126, 1996.
DOI : 10.1042/bj3150119

M. Pereira, B. Silva, M. Pinto, E. Barreto-bergter, and A. Santos, Proteins and Peptidases from Conidia and Mycelia of Scedosporium apiospermum Strain HLPB, Mycopathologia, vol.44, issue.1, pp.25-30, 2009.
DOI : 10.1099/00221287-147-6-1499

B. Silva, A. Souza-gonçalves, M. Pinto, E. Barreto-bergter, and A. Santos, Metallopeptidase inhibitors arrest vital biological processes in the fungal pathogen Scedosporium apiospermum, Mycoses, vol.17, issue.2, pp.105-112, 2011.
DOI : 10.1023/B:BIOM.0000029438.97990.c6

O. Lima, G. Larcher, and P. Vandeputte, Molecular cloning and biochemical characterization of a Cu,Zn-superoxide dismutase from Scedosporium apiospermum, Microbes and Infection, vol.9, issue.5, pp.558-565, 2007.
DOI : 10.1016/j.micinf.2007.01.027

S. Mina, A. Marot-leblond, and B. Cimon, ABSTRACT, Clinical and Vaccine Immunology, vol.32, issue.1, pp.37-45, 2015.
DOI : 10.1007/BF01962169

S. Mina, C. Staerck, and S. Almeida, Identification of Scedosporium boydii catalase A1 gene, a reactive oxygen species detoxification factor highly expressed in response to oxidative stress and phagocytic cells, Fungal Biology, vol.119, issue.12, pp.1322-1333, 2015.
DOI : 10.1016/j.funbio.2015.09.007

C. Staerck, P. Vandeputte, and A. Gastebois, Enzymatic Mechanisms Involved in Evasion of Fungi to the Oxidative Stress: Focus on Scedosporium apiospermum, Mycopathologia, vol.119, issue.6, pp.227-239, 2018.
DOI : 10.1016/j.funbio.2015.09.007

K. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001.
DOI : 10.1006/meth.2001.1262

D. Roos, Chronic granulomatous disease, British Medical Bulletin, vol.27, issue.1, pp.50-63, 2016.
DOI : 10.1038/ng1058
URL : https://hal.archives-ouvertes.fr/hal-00382226

R. Kenney, K. Kwon-chung, and A. Waytes, Successful Treatment of Systemic Exophiala dermatitidis Infection in a Patient with Chronic Granulomatous Disease, Clinical Infectious Diseases, vol.14, issue.1, pp.235-242, 1992.
DOI : 10.1093/clinids/14.1.235

P. Santos, M. Oleastro, M. Galicchio, and M. Zelazko, Fungal infections in paediatric patients with chronic granulomatous disease, Rev Iberoam Micol, vol.17, pp.6-9, 2000.

S. Bhat, D. Paterson, M. Rinaldi, and P. Veldkamp, Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with voriconazole and terbinafine, Scandinavian Journal of Infectious Diseases, vol.33, issue.1, pp.87-90, 2007.
DOI : 10.1111/j.1442-9071.2005.01045.x

S. Giraud, M. Pihet, and B. Razafimandimby, Geosmithia argillacea: an Emerging Pathogen in Patients with Cystic Fibrosis, Journal of Clinical Microbiology, vol.48, issue.7, pp.2381-2386, 2010.
DOI : 10.1128/JCM.00047-10
URL : http://jcm.asm.org/content/48/7/2381.full.pdf

M. Briones-martin-del-campo, E. Orta-zavalza, and J. Juarez-cepeda, The oxidative stress response of the opportunistic fungal pathogen Candida glabrata, Revista Iberoamericana de Micolog??a, vol.31, issue.1, pp.67-71, 2014.
DOI : 10.1016/j.riam.2013.09.012

S. Ghamrawi, A. Gastebois, and A. Zykwinska, A Multifaceted Study of Scedosporium boydii Cell Wall Changes during Germination and Identification of GPI-Anchored Proteins, PLOS ONE, vol.280, issue.Suppl 1, p.128680, 2015.
DOI : 10.1371/journal.pone.0128680.s003
URL : https://hal.archives-ouvertes.fr/hal-01392256

K. Lambou, C. Lamarre, R. Beau, N. Dufour, and J. Latgé, Molecular Microbiology, vol.178, issue.Suppl 1, pp.910-923, 2010.
DOI : 10.4049/jimmunol.178.10.6367

A. Alarco and R. M. , The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans, J Bacteriol, vol.181, pp.700-708, 1999.

C. Fradin, D. Groot, P. Maccallum, and D. , Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood, Molecular Microbiology, vol.97, issue.2, pp.397-415, 2005.
DOI : 10.1128/jb.179.7.2202-2209.1997

A. Tillmann, K. Strijbis, and G. Cameron, Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans, PLOS ONE, vol.181, issue.6, p.126940, 2015.
DOI : 10.1371/journal.pone.0126940.s003

T. Missall, M. Pusateri, M. Donlin, K. Chambers, J. Corbett et al., Posttranslational, Translational, and Transcriptional Responses to Nitric Oxide Stress in Cryptococcus neoformans: Implications for Virulence, Eukaryotic Cell, vol.5, issue.3, pp.518-529, 2006.
DOI : 10.1128/EC.5.3.518-529.2006

S. Paris, D. Wysong, and J. Debeaupuis, Catalases of Aspergillus fumigatus, Infection and Immunity, vol.71, issue.6, pp.3551-3562, 2003.
DOI : 10.1128/IAI.71.6.3551-3562.2003

S. Giles, J. Stajich, and C. Nichols, The Cryptococcus neoformans Catalase Gene Family and Its Role in Antioxidant Defense, Eukaryotic Cell, vol.5, issue.9, pp.1447-1459, 2006.
DOI : 10.1128/EC.00098-06

D. Wysong, C. L. Sugar, A. Robbins, P. Diamond, and R. , Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene, Infect Immun, vol.66, pp.1953-1961, 1998.

F. Hillmann, K. Bagramyan, and M. Straßburger, The Crystal Structure of Peroxiredoxin Asp f3 Provides Mechanistic Insight into Oxidative Stress Resistance and Virulence of Aspergillus fumigatus, Scientific Reports, vol.93, issue.1, p.33396, 2016.
DOI : 10.1111/mmi.12679

A. Abadio, E. Kioshima, M. Teixeira, N. Martins, B. Maigret et al., Comparative genomics allowed the identification of drug targets against human fungal pathogens, BMC Genomics, vol.8, issue.1, p.75, 2011.
DOI : 10.1093/bioinformatics/btg180
URL : https://hal.archives-ouvertes.fr/inria-00610630

G. Ianiri and A. Idnurm, Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization, MBio, vol.6, pp.2334-2348, 2015.

B. Enjalbert, A. Nantel, and M. Whiteway, : Absence of a General Stress Response, Molecular Biology of the Cell, vol.19, issue.4, pp.1460-1467, 2003.
DOI : 10.1002/yea.831

H. Kusch, S. Engelmann, D. Albrecht, J. Morschhäusermorschh¨morschhäuser, and M. Hecker, Proteomic analysis of the oxidative stress response inCandida albicans, PROTEOMICS, vol.198, issue.5, pp.686-697, 2007.
DOI : 10.1128/MCB.17.12.6982

N. Zaki, F. Bakar, N. Mahadi, and A. Murad, Candida albicans TRR1 heterozygotes show increased sensitivity to oxidative stress and decreased pathogenicity, Afr J Microbiol Res, vol.6, pp.1796-1805, 2012.

J. Godoy, E. Kioshimá, A. Abadio, M. Felipe, S. De-freitas et al., Structural and functional characterization of the recombinant thioredoxin reductase from Candida albicans as a potential target for vaccine and drug design, Applied Microbiology and Biotechnology, vol.9, issue.13, pp.4015-4025, 2015.
DOI : 10.2174/138945011501140115112242

C. Roder and M. Thomson, Auranofin: Repurposing an Old Drug for a Golden New Age, Drugs in R&D, vol.193, issue.7, pp.13-20, 2015.
DOI : 10.1128/JB.01063-10

M. Harbut, C. Vilchèze, and X. Luo, Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis, Proceedings of the National Academy of Sciences, vol.63, issue.2, pp.4453-4458, 2015.
DOI : 10.1038/ja.2014.36

B. Fuchs, R. Rajamuthiah, and A. Souza, Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin, Future Medicinal Chemistry, vol.254, issue.18, pp.117-132, 2016.
DOI : 10.3390/molecules15042203

S. Thangamani, H. Mohammad, and M. Abushahba, Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens, Scientific Reports, vol.9, issue.1, p.22571, 2016.
DOI : 10.1371/journal.pone.0116259

S. Thangamani, H. Mohammad, M. Abushahba, T. Sobreira, and M. Seleem, Repurposing auranofin for the treatment of cutaneous staphylococcal infections, International Journal of Antimicrobial Agents, vol.47, issue.3, pp.195-201, 2016.
DOI : 10.1016/j.ijantimicag.2015.12.016
URL : http://europepmc.org/articles/pmc4792765?pdf=render

N. Wiederhold, T. Patterson, and A. Srinivasan, activity against a variety of medically important fungi, Virulence, vol.8, issue.2, pp.138-142, 2016.
DOI : 10.1080/13693780802510224

K. Lapp, V. ¨. , M. Kroll, and K. , Characterization of the Aspergillus fumigatus detoxification systems for reactive nitrogen intermediates and their impact on virulence, Frontiers in Microbiology, vol.381, issue.e1000868, p.469, 2014.
DOI : 10.1016/j.bbrc.2009.01.112